Palatin Technologies (PTN) Higher On Collaboration Deal with AstraZeneca
Tweet Send to a Friend
Palatin Technologies (Amex: PTN) is 30% higher this morning after the company and AstraZeneca (NYSE: AZN) announced an exclusive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
